Wnt5a: A promising therapeutic target in ovarian cancer

Zuidervaart, 2007, Expression of Wnt5a and its downstream effector β-catenin in uveal melanoma, Melanoma Res., 17, 380, 10.1097/CMR.0b013e3282f1d302 Akiri, 2009, Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma, Oncogene, 28, 2163, 10.1038/onc.2009.82 Sherwood, 2015, WNT signaling: an emerging mediator of cancer cell metabolism?, Mol. Cell. Biol., 35, 2, 10.1128/MCB.00992-14 Larson, 2014, Melanoma spheroid formation involves laminin-associated vasculogenic mimicry, Am. J. Pathol., 184, 71, 10.1016/j.ajpath.2013.09.020 Qi, 2012, Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression, Cancer Sci., 103, 828, 10.1111/j.1349-7006.2012.02222.x Arend, 2013, The Wnt/β-catenin pathway in ovarian cancer: a review, Gynecol. Oncol., 131, 772, 10.1016/j.ygyno.2013.09.034 Prosperi, 2010, A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer, Curr. Drug Targets, 11, 1074, 10.2174/138945010792006780 Hseu, 2012, The antitumor activity of Antrodia camphorata in melanoma cells: modulation of wnt/β-Catenin signaling pathways, Evid. Complement. Alternat. Med. Teng, 2010, Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells, Biochem. Biophys. Res. Commun., 392, 373, 10.1016/j.bbrc.2010.01.028 Monga, 2009, Role of Wnt/β-catenin signaling in liver metabolism and cancer, Int. J. Biochem. Cell Biol., 43, 1021, 10.1016/j.biocel.2009.09.001 Bazhin, 2010, cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca(2+) homeostasis in melanoma cells, Cell. Mol. Life Sci., 67, 817, 10.1007/s00018-009-0214-0 Semenov, 2007, SnapShot: noncanonical wnt signaling pathways, Cell, 131, 1378, 10.1016/j.cell.2007.12.011 Verkaar, 2010, A model for signaling specificity of Wnt/Frizzled combinations through co-receptor recruitment, FEBS Lett., 584, 3850, 10.1016/j.febslet.2010.08.030 Sato, 2010, Wnt5a regulates distinct signalling pathways by binding to Frizzled2, EMBO J., 29, 41, 10.1038/emboj.2009.322 Bourhis, 2010, Reconstitution of a Frizzled8{middle dot}Wnt3a{middle dot}LRP6 signaling complex reveals multiple wnt and Dkk1 binding sites on LRP6, J. Biol. Chem., 285, 9172, 10.1074/jbc.M109.092130 Clark, 1993, Molecular cloning of the human proto-oncogene Wnt-5A and mapping of the gene (WNT5A) to chromosome 3p14-p21, Genomics, 18, 249, 10.1006/geno.1993.1463 Bellon, 2013, Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation, Blood, 121, 5045, 10.1182/blood-2012-07-439109 Saling, 2017, Wnt5a / planar cell polarity signaling pathway in urothelial carcinoma, a potential prognostic biomarker, Oncotarget, 8, 31655, 10.18632/oncotarget.15877 Chen, 2018, MicroRNA-374a inhibits aggressive tumor biological behavior in bladder carcinoma by suppressing wnt/β-Catenin signaling, Cell. Physiol. Biochem., 48, 815, 10.1159/000491911 Leandersson, 2006, Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells, Nucleic Acids Res., 34, 3988, 10.1093/nar/gkl571 Prasad, 2018, WNT5A as a therapeutic target in breast cancer, Cancer Metastasis Rev., 37, 767, 10.1007/s10555-018-9760-y Shojima, 2015, Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively, Sci. Rep., 5, 8042, 10.1038/srep08042 Yu, 2016, Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation, J. Clin. Invest., 126, 585, 10.1172/JCI83535 Linke, 2017, WNT5A: a motility-promoting factor in Hodgkin lymphoma, Oncogene, 36, 13, 10.1038/onc.2016.183 Cheng, 2014, Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition, J. Cell. Physiol., 229, 1908, 10.1002/jcp.24566 Lyros, 2016, Dysregulation of WNT5A/ROR2 signaling characterizes the progression of barrett-associated esophageal adenocarcinoma, Mol. Cancer Res., 14, 647, 10.1158/1541-7786.MCR-15-0484 Yamamoto, 2009, Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells, Gastroenterology, 137, 242, 10.1053/j.gastro.2009.02.003 Binda, 2017, Wnt5a drives an invasive phenotype in human glioblastoma stem-like cells, Cancer Res., 77, 996, 10.1158/0008-5472.CAN-16-1693 Hu, 2020, lncRNA MSC-AS1 activates Wnt/β-catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR-3924/WNT5A, J. Cell. Biochem., 121, 4085, 10.1002/jcb.29594 Chen, 2018, LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation, Oncogene, 37, 3098, 10.1038/s41388-018-0203-6 Da Forno, 2008, WNT5A expression increases during melanoma progression and correlates with outcome, Clin. Cancer Res., 14, 5825, 10.1158/1078-0432.CCR-07-5104 Qin, 2015, WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis, Oncotarget, 6, 10239, 10.18632/oncotarget.3518 Huang, 2005, Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer, J. Clin. Oncol., 23, 8765, 10.1200/JCO.2005.02.2871 Ripka, 2007, WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer, Carcinogenesis, 28, 1178, 10.1093/carcin/bgl255 Enomoto, 2009, Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling, Oncogene, 28, 3197, 10.1038/onc.2009.175 Kremenevskaja, 2005, Wnt-5a has tumor suppressor activity in thyroid carcinoma, Oncogene, 24, 2144, 10.1038/sj.onc.1208370 Mikels, 2006, Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context, PLoS Biol., 4, e115, 10.1371/journal.pbio.0040115 Yamamoto, 2010, Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase, Oncogene, 29, 2036, 10.1038/onc.2009.496 Ren, 2019, Wnt5a induces and maintains prostate cancer cells dormancy in bone, J. Exp. Med., 216, 428, 10.1084/jem.20180661 Badiglian Filho, 2009, Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer, Oncol. Rep., 21, 313 Ozols, 2004, Focus on epithelial ovarian cancer, Cancer Cell, 5, 19, 10.1016/S1535-6108(04)00002-9 Farley, 2008, Genomic analysis of epithelial ovarian cancer, Cell Res., 18, 538, 10.1038/cr.2008.52 Henry, 2015, Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion, Oncotarget, 6, 40310, 10.18632/oncotarget.5643 Wu, 2004, A model based background adjustment for oligonucleotide expression arrays, J. Am. Stat. Assoc., 99, 909, 10.1198/016214504000000683 Peng, 2011, Wnt5a as a predictor in poor clinical outcome of patients and a mediator in chemoresistance of ovarian cancer, Int. J. Gynecol. Cancer, 21, 280, 10.1097/IGC.0b013e31820aaadb Barbolina, 2011, Diverse mechanisms for activation of WNT signalling in the ovarian tumor microenvironment, Biochem. J., 437, 1, 10.1042/BJ20110112 Asem, 2020, Host Wnt5a potentiates microenvironmental regulation of ovarian cancer metastasis, Cancer Res., 80, 10.1158/0008-5472.CAN-19-1601 Kotrbová, 2020, WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer, Theranostics, 10, 537, 10.7150/thno.37423 Jin, 2018, The role of abnormal methylation of Wnt5a gene promoter regions in human epithelial ovarian Cancer: a clinical and experimental study, Anal. Cell. Pathol. (Amst), 2018 Lee, 2012, Wnt/Snail signaling regulates cytochrome C oxidase and glucose metabolism, Cancer Res., 72, 3607, 10.1158/0008-5472.CAN-12-0006 Thiery, 2009, Epithelial-mesenchymal transitions in development and disease, Cell, 139, 871, 10.1016/j.cell.2009.11.007 Dissanayake, 2007, The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition, J. Biol. Chem., 282, 17259, 10.1074/jbc.M700075200 Jordan, 2013, SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling, Mol. Cell. Biol., 33, 3011, 10.1128/MCB.01443-12 Abedini, 2020, Non-canonical WNT5a regulates Epithelial-to-Mesenchymal Transition in the mouse ovarian surface epithelium, Sci. Rep., 10, 10.1038/s41598-020-66559-9 Ford, 2014, The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer, Gynecol. Oncol., 134, 338, 10.1016/j.ygyno.2014.06.004 Mei, 2019, A DAAM1 3’-UTR SNP mutation regulates breast cancer metastasis through affecting miR-208a-5p-DAAM1-RhoA axis, Cancer Cell Int., 19, 55, 10.1186/s12935-019-0747-8 Mei, 2020, Overexpressed DAAM1 correlates with metastasis and predicts poor prognosis in breast cancer, Pathol. Res. Pract., 216, 10.1016/j.prp.2019.152736 Zhu, 2012, Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration, PLoS One, 7, 10.1371/journal.pone.0037823 Mei, 2019, DAAM1-mediated migration and invasion of ovarian cancer cells are suppressed by miR-208a-5p, Pathol. Res. Pract., 215, 10.1016/j.prp.2019.152452 Kuilman, 2010, The essence of senescence, Genes Dev., 24, 2463, 10.1101/gad.1971610 Judith, 2007, Cellular senescence: when bad things happen to good cells, Nat. Rev. Mol. Cell Biol. Tai, 2007, p53 restoration leads to tumor senescence and regression: implications for cancer therapy, Gastroenterology, 133, 722, 10.1053/j.gastro.2007.06.043 Bitler, 2011, Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence, Cancer Res., 71, 6184, 10.1158/0008-5472.CAN-11-1341 Bernardi, 2007, Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies, Nature reviews, Mol. Cell Biol., 8, 1006 Mallette, 2004, Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence, Oncogene, 23, 91, 10.1038/sj.onc.1206886 Ferbeyre, 2000, PML is induced by oncogenic ras and promotes premature senescence, Genes Dev., 14, 2015, 10.1101/gad.14.16.2015 Varma, 2005, Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10, Oncol. Rep., 14, 925 Hung, 2014, Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway, Oncotarget, 5, 10.18632/oncotarget.2631 Wang, 2017, MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a, Am. J. Cancer Res., 7, 1177 Endo, 2012, Analysis of Wnt/planar cell polarity pathway in cultured cells, Methods Mol. Biol. (Clifton, N.J.), 839, 201, 10.1007/978-1-61779-510-7_16 Katula, 2012, Differential regulation of the mouse and human Wnt5a alternative promoters A and B, DNA Cell Biol., 31, 1585, 10.1089/dna.2012.1698 Katoh, 2007, STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review), Int. J. Mol. Med., 19, 273 Arabzadeh, 2016, WNT5A–ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3, Cell. Mol. Biol. Lett., 21, 10.1186/s11658-016-0003-3 Cairns, 2011, Regulation of cancer cell metabolism, Nat. Rev. Cancer, 11, 85, 10.1038/nrc2981 Zoncu, 2011, mTOR: from growth signal integration to cancer, diabetes and ageing, Nat. Rev. Mol. Cell Biol., 12, 21, 10.1038/nrm3025 Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809 Sengupta, 2010, Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress, Mol. Cell, 40, 310, 10.1016/j.molcel.2010.09.026 Prasad, 2017, Reduced production and uptake of lactate are essential for the ability of WNT5A signaling to inhibit breast cancer cell migration and invasion, Oncotarget, 8, 71471, 10.18632/oncotarget.17277